Richard Brounstein's Net Worth
-$1.86 Thousand
Who is Richard Brounstein?
Richard Brounstein does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include NewCardio, Inc., HeartBeam, Inc., and CALYPTE BIOMEDICAL CORP.
SEC CIK
Richard Brounstein's CIK is 0001189694
Past Insider Trading and Trends
2022 was Richard Brounstein's most active year for acquiring shares with 18 total transactions. Richard Brounstein's most active month to acquire stocks was the month of February. 2022 was Richard Brounstein's most active year for disposing of shares, totalling 10 transactions. Richard Brounstein's most active month to dispose stocks was the month of June. 2007 saw Richard Brounstein paying a total of $200,000.01 for 9,615,385 shares, this is the most they've acquired in one year. In 2023 Richard Brounstein cashed out on 727 shares for a total of $2,675.36, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NewCardio, Inc. No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HeartBeam, Inc. (BEAT) Snapshot price: $1.805
Chief Financial OfficerRichard Brounstein owns 204,183 units of Common Stock which is worth $368,550.32. From 2021 to 2023 Richard Brounstein acquired a total of 49,987 shares in HeartBeam, Inc. at a cost of $170,410.02.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.16% | 184 |
—
|
—
| 112.11K |
Feb 10
| |||
Form 4
| +0.68% | 760 |
—
| $0.23 | 111.92K |
Dec 2
| |||
Form 4
| +0.69% | 759 |
—
| $0.23 | 111.16K |
Nov 2
| |||
Form 4
| +0.69% | 760 |
—
| $0.23 | 110.41K |
Oct 2
| |||
Form 4
| +0.70% | 757 |
—
| $0.23 | 109.64K |
Sep 2
| |||
Form 4
| +0.70% | 757 |
—
| $0.23 | 108.89K |
Aug 1
| |||
Form 4/A
| +0.71% | 757 |
—
| $0.23 | 108.13K |
Jul 5
| |||
Form 4
| +0.71% | 757 |
$1.30 | $984.10 | 108.13K |
Jul 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
| +0.71% | 757 |
—
| $0.23 | 107.37K |
Jun 2
| |||
Form 4
| +0.72% | 757 |
—
| $0.23 | 106.62K |
May 2
| |||
Form 4
| +0.72% | 757 |
—
|
—
| 105.86K |
Mar 30 - Apr 4
| |||
Form 4
| +0.73% | 757 |
—
| $0.23 | 105.1K |
Mar 2
| |||
Form 4
| +0.73% | 757 |
—
|
—
| 104.35K |
Feb 2
| |||
Form 4
| +1.48% | 1.51K |
—
| $0.45 | 103.59K |
Jan 2
| |||
Form 4
| +5.15% | 5K |
$3.37 | $16,846.00 | 102.08K |
Dec 21
| |||
Form 4
| +22.07% | 34.2K |
$5.10 | $152,577.40 | 189.15K |
Nov 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CALYPTE BIOMEDICAL CORP No price found
Executive Vice PresidentRichard Brounstein owns 3,846,154 units of Common stock, $0.03 par value. From 2003 to 2007 Richard Brounstein acquired a total of 3,846,154 shares in CALYPTE BIOMEDICAL CORP at a cost of $200,000.01.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.85M |
$0.05 | $200,000.01 | 3.85M |
Mar 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||